Memphasys Limited (MEM.AX)

AUD 0.01

(0.0%)

Total Assets Summary of Memphasys Limited

  • Memphasys Limited's latest annual total assets in 2024 was 12.43 Million AUD , down -15.26% from previous year.
  • Memphasys Limited's latest quarterly total assets in 2024 FY was 12.43 Million AUD , down -15.26% from previous quarter.
  • Memphasys Limited reported annual total assets of 14.66 Million AUD in 2023, up 3.87% from previous year.
  • Memphasys Limited reported annual total assets of 14.12 Million AUD in 2022, down -3.15% from previous year.
  • Memphasys Limited reported quarterly total assets of 13.14 Million AUD for 2024 Q2, down 0.0% from previous quarter.
  • Memphasys Limited reported quarterly total assets of 12.43 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual Total Assets Chart of Memphasys Limited (2024 - 2008)

Historical Annual Total Assets of Memphasys Limited (2024 - 2008)

Year Total Assets Total Assets Growth
2024 12.43 Million AUD -15.26%
2023 14.66 Million AUD 3.87%
2022 14.12 Million AUD -3.15%
2021 14.58 Million AUD 29.05%
2020 11.29 Million AUD 65.27%
2019 6.83 Million AUD 62.11%
2018 4.21 Million AUD -42.24%
2017 7.3 Million AUD 1.49%
2016 7.19 Million AUD 5.11%
2015 6.84 Million AUD -3.63%
2014 7.1 Million AUD -47.9%
2013 13.63 Million AUD 52.28%
2012 8.95 Million AUD -15.32%
2011 10.57 Million AUD -40.33%
2010 17.71 Million AUD 207.77%
2009 5.75 Million AUD 13.86%
2008 5.05 Million AUD 0.0%

Peer Total Assets Comparison of Memphasys Limited

Name Total Assets Total Assets Difference
AdAlta Limited 5.57 Million AUD -123.042%
Acrux Limited 8.96 Million AUD -38.683%
Race Oncology Limited 20.22 Million AUD 38.552%
Biome Australia Limited 8.27 Million AUD -50.181%
Botanix Pharmaceuticals Limited 112.46 Million AUD 88.948%
BTC Health Limited 5.14 Million AUD -141.418%
Chimeric Therapeutics Limited 15.27 Million AUD 18.614%
CSL Limited 56.93 Billion AUD 99.978%
Clarity Pharmaceuticals Ltd 154.62 Million AUD 91.961%
Clinuvel Pharmaceuticals Limited 231.12 Million AUD 94.622%
EZZ Life Science Holdings Limited 25.55 Million AUD 51.353%
Hexima Limited 2.26 Million AUD -447.824%
Immutep Limited 147.44 Million AUD 91.57%
Neuren Pharmaceuticals Limited 247.97 Million AUD 94.987%
Noxopharm Limited 6.78 Million AUD -83.234%
Prescient Therapeutics Limited 20.39 Million AUD 39.047%
Radiopharm Theranostics Limited 72.03 Million AUD 82.745%
Starpharma Holdings Limited 36.81 Million AUD 66.235%
Tissue Repair Ltd 19.38 Million AUD 35.893%
Biotron Limited 493.47 Thousand AUD -2418.896%
Alterity Therapeutics Limited 19.22 Million AUD 35.34%
Anatara Lifesciences Ltd 1.67 Million AUD -643.687%
Bio-Gene Technology Limited 3.15 Million AUD -293.41%
Zelira Therapeutics Limited 5.18 Million AUD -139.806%
Patrys Limited 4.16 Million AUD -198.688%
Orthocell Limited 26.61 Million AUD 53.297%
Imugene Limited 151.39 Million AUD 91.79%
PYC Therapeutics Limited 91.23 Million AUD 86.376%
Proteomics International Laboratories Limited 10.87 Million AUD -14.299%
Cynata Therapeutics Limited 8.38 Million AUD -48.185%
Arovella Therapeutics Limited 13.28 Million AUD 6.432%
Nanollose Limited 241.95 Thousand AUD -5037.465%
Invex Therapeutics Ltd 6.12 Million AUD -103.105%
NeuroScientific Biopharmaceuticals Limited 5.43 Million AUD -128.669%
Amplia Therapeutics Limited 14.84 Million AUD 16.268%
Island Pharmaceuticals Limited 2.56 Million AUD -384.706%
Nyrada Inc. 5.9 Million AUD -110.421%
Telix Pharmaceuticals Limited 398.3 Million AUD 96.879%
Dimerix Limited 32.07 Million AUD 61.251%
PharmAust Limited 11.12 Million AUD -11.733%
AnteoTech Limited 9.38 Million AUD -32.501%
Paradigm Biopharmaceuticals Limited 27.39 Million AUD 54.619%
Recce Pharmaceuticals Ltd 6.36 Million AUD -95.148%
Avecho Biotechnology Limited 7.31 Million AUD -69.827%
Actinogen Medical Limited 21.31 Million AUD 41.675%
Immuron Limited 15.54 Million AUD 20.063%
Argenica Therapeutics Limited 16.37 Million AUD 24.103%